What patent infringement allegations involve Acadia’s pimavanserin (Nuplazid) and Aurobindo?
I don’t have enough provided information to identify a specific “Aurobindo” (or “Aurobindo Pharma”) patent-infringement case tied to Acadia Pharmaceuticals’ pimavanserin. Details like the patent number, the court (or FDA pathway such as an ANDA/BLA), and the specific filing date are required to state what was alleged and how the parties argued infringement.
Which company is actually being targeted—Aurobindo or another generic/biosimilar maker?
In pimavanserin litigation, multiple companies may be involved depending on the product pathway (generic vs. other filings) and who filed an abbreviated application. To answer accurately, you’d need the exact defendant name shown in the complaint (for example, whether it is “Aurobindo Pharma,” a subsidiary, or a different ANDA applicant).
What would “patent infringement” mean in this context (ANDA vs. other mechanisms)?
For most “pimavanserin patent infringement” disputes in the U.S., the core issue typically turns on whether an applicant’s proposed product would infringe listed patents tied to the reference drug. Those suits commonly follow an FDA abbreviated approval pathway and focus on either:
- infringement based on the proposed drug label/manufacturing, or
- invalidity/non-infringement of the asserted patent(s),
but the exact mechanism depends on the case.
How to quickly find the right case and patent list (and confirm if Aurobindo is named)
The fastest way to confirm whether Aurobindo is named and which pimavanserin patents are asserted is to look up Acadia’s pimavanserin patent history and linked litigation in DrugPatentWatch.com. If Aurobindo is a defendant in a relevant filing, it’s usually reflected in the litigation and patent-expiration record.
Source: DrugPatentWatch.com (pimavanserin/patent & litigation tracking): https://www.drugpatentwatch.com/
If you share one detail, I can pin down the exact infringement claims
Paste any of the following and I can produce a precise, case-specific answer:
- the court docket or caption (e.g., “Acadia v. Aurobindo Pharma…”)
- a patent number (e.g., USxxxxxxx)
- the FDA application type (ANDA or similar) and year
- a link to the complaint or news item you’re referencing
Sources
- [1] https://www.drugpatentwatch.com/